Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00088179
Status:
COMPLETED
Last Update Posted:
2018-02-22
First Post:
2004-07-21
Brief Title:
Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass PRIMO-CABG II
Sponsor:
Alexion Pharmaceuticals Inc
Organization:
Alexion Pharmaceuticals Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-07
Start Date Type:
ACTUAL
Primary Completion Date:
2005-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-10
Completion Date Type:
ACTUAL
First Submit Date:
2004-07-21
First Submit QC Date:
July 22 2004
Study First Post Date:
2004-07-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2017-02-15
Disp First Submit QC Date:
February 15 2017
Disp First Post Date:
2017-02-16
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2018-02-20
Last Update Post Date:
2018-02-22
Last Update Post Date Type:
ACTUAL